about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesNewer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overviewNeuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsNeuroendocrine tumors of the gastro-entero-pancreatic systemIn vivo imaging of molecular targets and their function in endocrinology.Ectopic insulin secreting neuroendocrine tumor of kidney with recurrent hypoglycemia: a diagnostic dilemma.Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasSomatostatin receptor based imaging and radionuclide therapy.Cancer stratification by molecular imaging.Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndromeDiffuse nesidioblastosis diagnosed on a Ga-68 DOTATATE positron emission tomography/computerized tomographyGastric acid hypersecretory states: recent insights and advances.Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead.Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.Neuroendocrine tumours: the role of imaging for diagnosis and therapy.Synthesis and preliminary biological evaluation of O-2((2-[(18)F]fluoroethyl)methylamino)ethyltyrosine ([(18)F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.Low Grade Neuroendocrine Tumors of the Lung.Sunitinib malate as first-line treatment for an advanced, poorly differentiated pancreatic neuroendocrine tumor.Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.Fluorine-18 labeled amino acids for tumor PET/CT imagingDiagnosis of pancreatic neuroendocrine tumors and the role of endoscopic ultrasound.Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.PET-Guided Surgery - High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours.Technetium-99m complexes of l-arginine derivatives for targeting amino acid transporters.Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.[PET-CT for neuroendocrine tumors and nuclear medicine therapy options].Advanced typical and atypical carcinoid tumours of the lung: management recommendations.
P2860
Q24603675-76BDF089-249B-4F62-8C2A-26F4303AD434Q26767172-0109003C-215C-4A94-AC43-D42A8BAD417EQ28285545-4D5E36C2-AD7D-4429-98FE-539828E0E4C3Q28290833-E0D7ECAE-67C4-46D6-9128-63AFDDA931D6Q28294432-5A853371-8836-4245-927A-95EA126AC339Q33637199-48D7DB15-238A-4122-B860-972511679B2BQ33713136-2150F163-555F-4B45-86E9-AD208E5A00CFQ33927124-07B04E6A-E752-4E1F-9E2F-DFD9DC90FB94Q34157385-401F7042-3665-41CF-B04C-DE0C241D49EDQ35001777-ED42777B-F720-4FEF-A96A-96EC85AE3C6FQ35296661-48C3EC7D-AB88-43C0-BAEA-6F0E2CE79060Q35380664-B291D706-E811-48F2-AC62-7D309B9CF029Q37231446-6C0314D0-A916-417D-A622-EABB56BC2A81Q37293630-E20F139B-82B1-4E8D-BAC8-2C7EF9041610Q37474172-4B4D17B3-348C-4211-866F-BC9624775B34Q37947138-B866F7E7-03EB-4255-AE5C-EE31BC9D9935Q37962416-A35FB694-D7F4-4057-B489-27BDC684F9B2Q37990397-88672DB0-1B6D-4A87-A157-F84672895487Q38036127-5FF756D5-482A-4070-B8E2-4AE7C4EEA0B5Q38052101-8AB9A08A-F5CD-41AC-B807-A72E102F8BADQ38123057-060E1D36-79D7-4BF2-9104-C86A87B3F319Q38169928-F2A8D21D-7D57-4137-B8FE-398A67BCAF9AQ38997841-B49123F3-C53D-4C15-A181-57F1811224C6Q39016753-37F42EFA-6EF6-4142-8170-7694AC88A2F6Q39403750-BCF0D96B-F198-4312-8160-CB5B716E4CDCQ39411115-1EA030C6-8D76-4CA9-94CA-3735555FC26EQ39973557-83D1FF44-E171-4404-A0D9-6CAC9FEA0067Q41694062-A4310569-C7EC-4AE7-8E14-A273D9C45371Q42413519-79863BCB-FDBA-4D37-A037-10CAD9565C91Q42469904-4882A413-DAA3-4302-B895-AFE89A9ED433Q43089965-2C00B76E-C53D-473B-B060-5DF60FCC1DB0Q50585708-25312084-DFAD-4632-AB5C-35B6952C1668Q51510849-EED6FEA1-9623-4C0C-BE5A-3AABB9D5B02EQ52953312-F317816F-D3BF-486D-9F76-59FFE5671F4BQ53363572-C2111734-ACC0-4244-8CE3-37A6AA75DDD9Q55332915-5D45C01A-B48D-4E2A-A8FE-A93403043E03
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nuclear imaging of neuroendocrine tumours.
@ast
Nuclear imaging of neuroendocrine tumours.
@en
type
label
Nuclear imaging of neuroendocrine tumours.
@ast
Nuclear imaging of neuroendocrine tumours.
@en
prefLabel
Nuclear imaging of neuroendocrine tumours.
@ast
Nuclear imaging of neuroendocrine tumours.
@en
P2093
P1476
Nuclear imaging of neuroendocrine tumours.
@en
P2093
Anders Sundin
Håkan Orlefors
Ulrike Garske
P356
10.1016/J.BEEM.2006.12.003
P577
2007-03-01T00:00:00Z